A poisoned legacy: challenging the EPA’s reluctance to ban glyphosate amidst rising health concerns

Unveiling the controversy: a deep dive into the legal, scientific, and humanitarian debate over glyphosate's future


The controversy surrounding glyphosate, a widely used herbicide, has reached a critical juncture. A coalition of environmental and farmworker groups, led by the Center for Food Safety (CFS), has launched a groundbreaking legal action against the U.S. Environmental Protection Agency (EPA). This move comes in response to a body of scientific research, including recent findings from the U.S. National Institutes of Health (NIH), that links glyphosate to serious health issues. Initially celebrated for its effectiveness, glyphosate, the key ingredient in Monsanto’s Roundup, now finds itself at the center of a health and environmental crisis.

The current legal challenge intensifies the scrutiny on the EPA’s decision-making process regarding chemical safety. With increasing evidence of glyphosate’s potential harm, particularly to farmworkers and their families, this legal action represents a critical moment in the ongoing debate over the safety of widely used agricultural chemicals.

In an unprecedented move, the CFS, representing Beyond Pesticides and four farmworker advocacy groups, including Alianza Nacional de Campesinas, has declared glyphosate’s registration in the U.S. illegal. This bold assertion follows the recent publication of an NIH study in Environmental Health Perspectives. The study’s alarming findings point to ‘markers of genotoxicity’ in male farmers exposed to high levels of glyphosate, adding to the growing concerns about the herbicide’s safety.

This legal action is not just a response to the NIH study but a culmination of years of mounting evidence against glyphosate. The petition challenges the EPA to reconsider its stance and acknowledge the potential dangers posed by this herbicide. It marks a significant escalation in the fight for stricter regulation of harmful chemicals and underscores the urgency of reevaluating glyphosate’s impact on human health.

Glyphosate’s story is a tale of shifting perceptions. Initially hailed as a breakthrough in agricultural technology by Monsanto (now part of Bayer), glyphosate’s rise to prominence was meteoric. However, this ascent was soon marred by controversy as studies began to surface linking the herbicide to various health risks, particularly cancer. The subsequent legal battles, most notably in 2018 and 2019, saw juries award over $2.3 billion in damages against Monsanto for failing to warn about Roundup’s risks, casting a long shadow over the herbicide’s safety.

These legal setbacks for Monsanto highlighted a growing public awareness and concern about glyphosate. The lawsuits not only brought to light the potential dangers of the herbicide but also raised questions about the transparency and accountability of large agrochemical corporations. This history of legal struggles and scientific debate has set the stage for the current legal challenge against the EPA, further intensifying the scrutiny of glyphosate’s safety.

The body of scientific evidence against glyphosate is formidable. Numerous studies, including those from the World Health Organization’s International Agency for Research on Cancer, have suggested a link between glyphosate and cancer, classifying it as “probably carcinogenic to humans.” This classification in 2015 was a significant moment, as it contradicted many existing safety assessments of glyphosate and sparked a global debate on its use.

In addition to cancer risks, research has indicated other potential health effects of glyphosate, such as its impact on the liver, kidneys, and reproductive system. These findings have not only influenced public opinion but have also played a crucial role in legal battles, as they challenge the narrative of glyphosate’s safety promoted by its manufacturers and some regulatory bodies. The growing scientific consensus around the risks associated with glyphosate has become a key element in the argument for its ban.

The human cost of glyphosate use has been most acutely felt by farmworkers and their families. Mily Treviño-Sauceda, the executive director of Alianza Nacional de Campesinas, speaks passionately about the devastating health effects that pesticides, including glyphosate, have had on these communities. Their stories of suffering and illness add a poignant, personal dimension to the scientific and legal debates surrounding glyphosate. These testimonies serve as powerful reminders of the real-world implications of chemical use in agriculture and the pressing need for regulatory action.

Advocates and environmentalists echo these concerns, emphasizing the urgent need for the EPA to act. They argue that the agency’s continued approval of glyphosate not only disregards the mounting scientific evidence but also fails to protect those most vulnerable to its effects. The voices of these frontline communities are crucial in understanding the full impact of glyphosate and the necessity of its reevaluation.

The legal and regulatory landscape surrounding glyphosate has been marked by significant battles and pivotal decisions. The U.S. Court of Appeals for the 9th Circuit’s ruling against the EPA’s assessment of glyphosate’s safety was a landmark moment. It underscored the growing disconnect between the regulatory agency’s decisions and the scientific and legal challenges they face. This decision has been instrumental in shaping the current legal actions against the EPA, highlighting the need for a more rigorous and transparent evaluation process.

This legal pressure on the EPA comes at a time when public trust in the agency’s ability to effectively regulate harmful chemicals is waning. Critics argue that the EPA has been slow to respond to scientific evidence and has failed to adequately consider the health risks posed by glyphosate. This section of the investigation delves into the intricacies of these legal battles and the implications they hold for the future of glyphosate regulation.

The EPA’s approach to regulating glyphosate has come under intense scrutiny. Despite the growing body of scientific evidence and the recent court rulings, the agency has been reluctant to change its position on glyphosate’s safety. This has raised serious questions about the EPA’s decision-making processes and its commitment to protecting public health and the environment. Critics argue that the agency has been overly influenced by the agrochemical industry and has failed to adequately consider independent scientific studies.

The EPA’s failure to act decisively on glyphosate is seen by many as symptomatic of a larger issue within the agency – a reluctance to challenge powerful corporate interests and a tendency to prioritize economic considerations over environmental and health concerns. This section explores the criticisms leveled against the EPA and the impact of its decisions on public health and environmental safety.

The debate over glyphosate extends far beyond U.S. borders. In contrast to the EPA’s stance, several European countries, including France, the Netherlands, Belgium, and Germany, have imposed restrictions or outright bans on glyphosate use. These international actions reflect a growing global consensus on the potential dangers of glyphosate and a more precautionary approach to chemical regulation.

This global perspective is crucial in understanding the broader implications of the glyphosate controversy. It highlights the differences in regulatory approaches and the potential for international standards to influence national policies. This section examines how the international handling of glyphosate challenges and informs the ongoing debate in the U.S.

As the legal and scientific debates continue, the future of glyphosate remains uncertain. The potential ban of glyphosate in the U.S. could have significant implications for agricultural practices, as well as for the broader issue of chemical safety regulation. This section explores the possible outcomes of the current legal actions and the broader implications for environmental policy and sustainable agriculture.

The discussion extends to alternative herbicides and farming methods that could replace glyphosate. The shift towards more sustainable and less harmful agricultural practices is presented as not only necessary for environmental and health reasons but also as a feasible and beneficial path forward.

As the legal battle against the EPA unfolds, it becomes increasingly clear that this is not just about one herbicide but about the broader issues of public health, environmental protection, and corporate accountability. The outcome of this case could set a precedent for how harmful chemicals are regulated in the future and how agencies like the EPA balance public welfare with economic interests. As Bill Freese, the science director at CFS, aptly puts it, “It’s time for the EPA to step up and prioritize the health of the environment and the people over the interests of the agrochemical industry.”


If you liked this article, please donate $5 to keep NationofChange online through November.